Table 3.

Experiment 2: Animal attrition and incidence and timing of autophagia

RatGroupDay of onsetSiteRelative to vectoraSeverity
27shPTEN-Fibrin4ForepawContralateralMild
31Untreated4ForepawContralateralSevere
33shPTEN-Fibrin7ForepawsBothModerate
18shPTEN-Fibrin11ForepawContralateralSevere
8shPTEN/shSOCS3-Fibrin13ForepawContralateralMild
37shPTEN/shSOCS3-Fibrin13ForepawContralateralModerate
8shPTEN/shSOCS3-Fibrin14ForepawIpsilateralMild
14shPTEN-Fibrin14ForepawIpsilateralMild
19shPTEN-Fibrin14ForepawContralateralMild
5Untreated15ForepawContralateralMild
2shPTEN/shSOCS3-Fibrin19HindpawContralateralMild
25Untreated22ForepawIpsilateralMild
9shPTEN/shSOCS3-Fibrin24ForepawContralateralMild
24shPTEN-Fibrin24HindpawContralateralModerate
26shPTEN/shSOCS3-Fibrin24ForepawContralateralModerate
40Untreated28HindpawContralateralSevere
10Untreated29HindpawIpsilateralMild
41shPTEN/shSOCS3-Fibrin30ForepawContralateralMild
46shPTEN/shSOCS3-Fibrin30HindpawIpsilateralMild
18shPTEN-Fibrin31HindpawIpsilateralModerate
21Untreated34ForepawIpsilateralMild
12shPTEN-Fibrin35HindpawContralateralMild
30Untreated39ForepawContralateralModerate
4shPTEN-Fibrin46HindpawContralateralMild
34shPTEN-Fibrin48ForepawContralateralMild
44shPTEN/shSOCS3-Fibrin54ForepawIpsilateralMild
31Untreated62HindpawContralateralModerate
30Untreated65ForepawIpsilateralModerate
48Untreated66HindpawIpsilateralModerate
41shPTEN/shSOCS3-Fibrin72HindpawIpsilateralMild
42shPTEN-Fibrin72HindpawIpsilateralMild
45shPTEN/shSOCS3-Fibrin72HindpawIpsilateralMild
46shPTEN/shSOCS3-Fibrin83ForepawIpsilateralMild
  • aLaterality in terms of AAV injection.